Implantable cardioverter-defibrillator prevents sudden death in patients with Chagas cardiomyopathy in the Brazilian Amazon.
Katia do Nascimento CouceiroJessica Vanina OrtizMônica Regina Hosannah da Silva E SilvaDébora Raysa Teixeira de SousaKenny Rodrigues de SouzaGabriela Maciel AlencarLaylah Kelre Costa MagalhãesMaria das Graças Vale Barbosa GuerraJoão Marcos Bemfica Barbosa FerreiraJorge Augusto de Oliveira GuerraPublished in: Revista da Sociedade Brasileira de Medicina Tropical (2021)
Chagas disease (CD), with approximately 10,000 deaths annually, has become a worldwide health problem. Approximately 35% of cases may show cardiac manifestations such as arrhythmias and/or conduction disorders, heart failure, thromboembolic accidents, and sudden death. The Amazon region has long been considered a non-endemic area for CD; however, in the last decades, with an increase in the number of acute and chronic cases, disease evolution has received greater attention. Here, we report the successful implementation of a cardioverter-defibrillator for the prevention of sudden death in a patient with autochthonous Chagas cardiomyopathy in the Brazilian Amazon.
Keyphrases
- heart failure
- healthcare
- left ventricular
- public health
- cardiac resynchronization therapy
- atrial fibrillation
- liver failure
- primary care
- trypanosoma cruzi
- drug induced
- mental health
- working memory
- respiratory failure
- quality improvement
- health information
- acute heart failure
- congenital heart disease
- mouse model
- human health
- risk assessment